Please wait...
About This Project
Oxidized forms of the peptide beta-amyloid (Aβ) are considered to be toxic to the brain, leading to the development of Alzheimer's disease (AD). Based on our preliminary data, we hypothesize that an immunization of an AD-model mice with a recombinant protein enriched with the oxidized amino acid methionine sulfoxide will cause the removal of toxic Aβ from brain. Consequently, this treatment is expected to inhibit the development of AD and alleviate cognitive impairment.
More Lab Notes From This Project
Browse Other Projects on Experiment
Related Projects
Open Insulin
A team of biohackers is developing the first open source protocol to produce insulin simply and economically...
Part 2: Can low carbohydrate ketogenic diets inhibit cancers?
We've identified that ketone bodies, i.e. fuels in the bloodstream that result from a very low carbohydrate...
Can perfluorocarbon liquids remove benzo(a)pyrene, a model carcinogen from cells?
Lung cancer is the single largest cause of cancer mortality, accounting for about 19% of all cancer deaths...